IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
この論文をさがす
抄録
type:text
[Abstract] Insulin-like growth factor binding proteins (IGFBPs) bind to and modulate the actionsof insulin-like growth factors (IGFs). Although some of the actions of IGFBPs havebeen reported to be independent of IGFs, the precise mechanisms of IGF-independentactions of IGFBPs are largely unknown. Here we report a previously unknownfunction for IGFBP-4 as a cardiogenic growth factor. IGFBP-4 enhancedcardiomyocyte differentiation in vitro, and knockdown of IGFBP-4 attenuatedcardiomyogenesis both in vitro and in vivo. The cardiogenic effect of IGFBP-4 wasindependent of its IGF binding activity but was mediated by the inhibitory effect oncanonical Wnt signaling. IGFBP-4 physically interacted with a Wnt receptor Frizzled 8(Frz8) and a Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6),and inhibited Wnt3A binding to Frz8 and LRP6. Although IGF-independent, thecardiogenic effect of IGFBP-4 was attenuated by IGFs through IGFBP-4 sequestration.Thus, IGFBP-4 is an inhibitor of canonical Wnt signaling required for cardiogenesis,and provides a molecular link between IGF signaling and Wnt signaling.
収録刊行物
-
- Nature
-
Nature 454 345-349, 2008-06-04
Nature Publishing Group
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050288547193388160
-
- NII論文ID
- 120007069172
-
- NII書誌ID
- AA00752384
-
- ISSN
- 00280836
- 14764687
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- CiNii Articles